CNS Network Chosen by Cognitive Research Corporation to Conduct Driving Simulation Crossover Study

CNS Network Chosen by Cognitive Research Corporation to Conduct Driving Simulation Crossover Study

GARDEN GROVE, Calif., October 10, 2017CNS Network, a leading clinical research center in Southern California, is pleased to announce that the company has been chosen by Cognitive Research Corporation to conduct a driving simulation cross-over study of the sedative effects of a muscle relaxant as compared to a different muscle relaxant and a placebo.

FDA draft guidance indicates that driving studies will be required for a broader range of compounds. The guidance indicates that a dedicated driving study will be necessary when “accumulating data suggest a potential for driving impairment.” The guidance also specifies that driving simulators are suitable for conducting these studies.

“Our company is well qualified to conduct this study,” said CNS Network CEO David P. Walling, Ph.D. “Our Long Beach facility has four state-of-the-art CRCDS MiniSim PC-based driving simulators dedicated to clinical trials.”

Developed by the University of Iowa, the CRCDS MiniSim driving simulator has been fully validated for use in clinical trials. The CRCDS MiniSim has proven sensitivity to alcohol, depressants, and stimulants, and is designed to study the effects of driving abilities in both normal and patient populations.

For more information about CNS Network conducting a driving simulator study for your company, please contact Bobbie Theodore at 916-939-6696 or via email at


About Cognitive Research Corporation
Cognitive Research Corporation (‘CRC’) is a privately-held, full-service contract research organization that specializes in Central Nervous System (CNS) product development, for the pharmaceutical, nutraceutical, biotechnology and medical device companies including unique expertise in managing driving simulation studies. With offices in Florida and relationships with experienced research facilities around the U.S. and Canada, CRC is well-positioned to conduct clinical studies at any stage, Phase I-IV.


About CNS Network
CNS Network is a recognized leader in conducting complex population and healthy subject clinical trials. Founded in 1999, its 40,000-square-foot, state-of-the-art clinical research center in Long Beach, Calif., features a 60-bed Clinical Research Unit (CRU) and a 20-bed, JCAHO-accredited, licensed psychiatric hospital.

Its four outpatient research centers, located in Garden Grove, Long Beach, Torrance and Oakland, Calif., give it access to a population of more than 20 million, enabling rapid recruit from more challenging populations to healthy volunteers.

CNS Network’s team of dedicated medical, regulatory, quality assurance, recruitment and coordinator staff members manage complex protocols and provide quality data. CNS Network is experienced in all phases of clinical research, helping sponsors plan and implement successful studies.


View this press release on